Summaries for patients. Treatment of Crohn disease with anti-tumor necrosis factor agent
- PMID: 17470825
Summaries for patients. Treatment of Crohn disease with anti-tumor necrosis factor agent
Original report in
-
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.Ann Intern Med. 2007 Jun 19;146(12):829-38. doi: 10.7326/0003-4819-146-12-200706190-00159. Epub 2007 Apr 30. Ann Intern Med. 2007. PMID: 17470824 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical